HSA Approval

MEDRINATE SYRUP 25 mg/5 ml

Approval Number

SIN07645P

Drug Name

Product Name

MEDRINATE SYRUP 25 mg/5 ml

Approval Date

January 10, 1994

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

A04AD

ATC Item Name

其它镇吐药

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

HOVID BHD

Active Ingredients

Ingredient Name

DIMENHYDRINATE

Strength

25 mg/5 ml

Drug MonographDimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

MEDRINATE SYRUP 25 mg/5 ml - HSA Approval | MedPath

AI-Powered Research

Premium Access

MEDRINATE SYRUP 25 mg/5 ml

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal